OPTIMOX1方案用于晚期结直肠癌：缺乏“停停走走”策略的证据 - Suppr | 超能文献

OPTIMOX1 in advanced colorectal cancer: lack of evidence for a stop-and-go strategy.

作者信息

Rosa Daniela D, Ismael Gustavo F V, de Azambuja Evandro, Braga Sofia, Cardoso Fatima, Bleiberg Harry

出版信息

J Clin Oncol. 2006 Nov 10;24(32):5176-7; author reply 5177. doi: 10.1200/JCO.2006.07.5630.

DOI:10.1200/JCO.2006.07.5630

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

OPTIMOX1 in advanced colorectal cancer: lack of evidence for a stop-and-go strategy.OPTIMOX1方案用于晚期结直肠癌：缺乏“停停走走”策略的证据

J Clin Oncol. 2006 Nov 10;24(32):5176-7; author reply 5177. doi: 10.1200/JCO.2006.07.5630.

2

FOLFOX in patients aged between 76 and 80 years with metastatic colorectal cancer: an exploratory cohort of the OPTIMOX1 study.76至80岁转移性结直肠癌患者使用FOLFOX方案：OPTIMOX1研究的一个探索性队列

Cancer. 2007 Dec 15;110(12):2666-71. doi: 10.1002/cncr.23091.

3

Prediction of survival by neutropenia according to delivery schedule of oxaliplatin-5-Fluorouracil-leucovorin for metastatic colorectal cancer in a randomized international trial (EORTC 05963).在一项随机国际试验（EORTC 05963）中，根据转移性结直肠癌奥沙利铂-5-氟尿嘧啶-亚叶酸的给药方案，中性粒细胞减少症对生存的预测。

Chronobiol Int. 2011 Aug;28(7):586-600. doi: 10.3109/07420528.2011.597532.

4

A phase II trial of modified FOLFOX as first-line chemotherapy in advanced colorectal cancer.改良FOLFOX方案作为晚期结直肠癌一线化疗的II期试验。

Anticancer Drugs. 2007 Oct;18(9):1103-7. doi: 10.1097/CAD.0b013e3281722010.

5

Safety and efficacy of modified FOLFOX6 for treatment of metastatic or locally advanced colorectal cancer. A single-institution outcome study.改良FOLFOX6方案治疗转移性或局部晚期结直肠癌的安全性和有效性。一项单机构结局研究。

Chemotherapy. 2008;54(5):395-403. doi: 10.1159/000154921. Epub 2008 Sep 9.

6

[Colorectal carcinoma--approval of eloxatine in adjuvant therapy--better chances for recovery].[结直肠癌——奥沙利铂在辅助治疗中的获批——康复机会增加]

Krankenpfl J. 2004;42(7-10):234.

7

The efficacy and toxicity of FOLFOX regimen (a combination of leucovorin and fluorouracil with oxaliplatin) as first-line treatment of metastatic colorectal cancer.FOLFOX方案（亚叶酸钙、氟尿嘧啶与奥沙利铂联合）作为转移性结直肠癌一线治疗的疗效与毒性

Gan To Kagaku Ryoho. 2009 May;36(5):797-801.

8

An increasingly common challenge: management of the complete responder with multi-focal metastatic colorectal cancer.一个日益常见的挑战：多灶性转移性结直肠癌完全缓解者的管理。

J Clin Oncol. 2005 Mar 20;23(9):1799-802. doi: 10.1200/JCO.2005.02.185.

9

A randomized phase II/III trial comparing hepatectomy followed by mFOLFOX6 with hepatectomy alone as treatment for liver metastasis from colorectal cancer: Japan Clinical Oncology Group Study JCOG0603.一项比较肝切除术后接受mFOLFOX6方案与单纯肝切除术治疗结直肠癌肝转移的随机II/III期试验：日本临床肿瘤学会研究JCOG0603

Jpn J Clin Oncol. 2009 Jun;39(6):406-9. doi: 10.1093/jjco/hyp035. Epub 2009 Apr 23.

10

Chemotherapy-free intervals in patients with metastatic colorectal cancer: a tale of two cities?转移性结直肠癌患者的无化疗间期：双城故事？

J Clin Oncol. 2010 Jun 1;28(16):e268-9; author reply e270. doi: 10.1200/JCO.2009.27.4720. Epub 2010 Apr 12.

引用本文的文献

1

[Painful hyperexcitability syndrome with oxaliplatin containing chemotherapy. Clinical features, pathophysiology and therapeutic options].[含奥沙利铂化疗所致疼痛性超敏反应综合征。临床特征、病理生理学及治疗选择]

Schmerz. 2008 Feb;22(1):16-23. doi: 10.1007/s00482-007-0552-5.